Doctors Drug Trials Life Science Vaccine 
pharmaphorum
DECEMBER 1, 2022
To ease this burden, the life sciences industry has been searching for ways to make clinical trials more accessible for patients and to drive participation numbers, increase participant diversity, and improve overall patient experience. Build a base in the community. Keep it simple. In fact, the opposite is true.
XTalks
FEBRUARY 25, 2022
Despite these statistics, in the US, Black people only constitute five percent of all clinical trial participants. The overwhelming majority of trial participants nationwide are white. This mistrust stems from both historic and continuing events in healthcare pertaining to issues of racial and socioeconomic discrimination.
Expert insights. Personalized for you.
104 
Let's personalize your content